FELIX BIOTECHNOLOGY INC
San Francisco, CA · Biotech · Defunct
Engineered lytic bacteriophages targeting Pseudomonas aeruginosa, created using proprietary CRISPR-based genetic engineering platform (ACE technology) for phage therapy of antibiotic-resistant infecti
felixbt.com →- Grants
- $1.9M
- 6 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓202120222023
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | National Science Foundation · Phase I · SBIR Phase I: Leveraging machine learning to enable generalized phage therapy for pulmonary infections | $256,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Microfluidics Platform for Rapid, High-throughput Screening of Therapeutic Bacteriophages Based on Patient Bacterial Isolates | $314,411 | |
| Federal grant | Department of Health and Human Services · Phase I · Microfluidics Platform for Rapid, High-throughput Screening of Therapeutic Bacteriophages Based on Patient Bacterial Isolates | $314,411 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase I · Developing generalized engineering tools to create enhanced phage therapy for the clinic and commercialization | $300,000 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase I · Developing generalized engineering tools to create enhanced phage therapy for the clinic and commercialization | $484,424 | |
| Federal grant | Department of Health and Human Services · Phase I · Developing generalized engineering tools to create enhanced phage therapy for the clinic and commercialization | $184,424 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2747 | APIS THERAPEUTICS, LLC | — | — |
| 2748 | Abvance Therapeutics | — | — |
| 2749 | JME Group Associates Inc | — | — |
| 2750 | FELIX BIOTECHNOLOGY INC | — | — |
| 2751 | Small Molecule PPI Mimics LLC | — | — |
| 2752 | LUMEN BIOSCIENCE, INC. | — | $50M |
| 2753 | Bicycle Therapeutics | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.